Long-term cognitive and somatic outcomes of enzyme replacement therapy in untransplanted Hurler syndrome

Mucopolysaccharidosis type I (MPS I) was added to the Recommended Uniform Screening Panel for newborn screening in 2016, highlighting recognition that early treatment of MPS I is critical to stem progressive, irreversible disease manifestations. Enzyme replacement therapy (ERT) is an approved treatm...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Mol Genet Metab Rep
Main Authors: Eisengart, Julie B., Jarnes, Jeanine, Ahmed, Alia, Nestrasil, Igor, Ziegler, Richard, Delaney, Kathleen, Shapiro, Elsa, Whitley, Chester
Formato: Artigo
Idioma:Inglês
Publicado em: Elsevier 2017
Assuntos:
Case Report
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5622996/
https://ncbi.nlm.nih.gov/pubmed/28983455
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ymgmr.2017.07.012
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados